Pancreatic cancer
Conditions
Interventions
None listed
Sponsors
Kagoshima University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1)Patients diagnosed with resectable (R) or borderline resectable (BR) pancreatic cancer based on abdominal CT images at initial presentation at our hospital or participating research institutions between January 1, 2019, and December 31, 2024. (2)Patients who underwent transpapillary stent placement (plastic or metal stents) for the purpose of reducing jaundice, followed by the initiation of neoadjuvant chemotherapy. (3)Patients who have undergone histological examination or cytological examination prior to registration but have not been diagnosed with neuroendocrine tumors (histological examination or cytological examination prior to registration is not mandatory) (4)Patients aged 20 or older on the date of registration. (5)Patients with appropriate organ function.
Exclusion criteria
Exclusion criteria: (1)Patients with unresectable pancreatic cancer. (2)The patient has not undergone neoadjuvant chemotherapy. (3)Patients with neuroendocrine tumors. (4)Patients under 20 years of age.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall survival | — |
Secondary
| Measure | Time frame |
|---|---|
| Feasibility of performing surgery Changes in nutritional status Association with perioperative complications Association with post-ERCP pancreatitis | — |
Countries
Japan
Contacts
Public ContactMakoto Hinokuchi
Kagoshima University Digestive and Lifestyle Diseases
Outcome results
None listed